Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active site driven ligand design: an evolutionary approach.

Sanghamitra Bandyopadhyay1, Angshuman Bagchi, Ujjwal Maulik

  • 1Machine Intelligence Unit, Indian Statistical Institute, Kolkata 700 108, India. sanghami@isical.ac.in

Journal of Bioinformatics and Computational Biology
|November 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers.

International journal of molecular sciences·2026
Same author

RSTG: Robust Generation of High Quality Spatial Transcriptomics Data using Beta Divergence Based AutoEncoder.

IEEE journal of biomedical and health informatics·2026
Same author

Optimizing genomics-aware clinical agents in precision oncology.

NPJ systems biology and applications·2026
Same author

Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell.

bioRxiv : the preprint server for biology·2026
Same author

Correction to "Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity".

ACS applied bio materials·2026
Same author

BKDRP: a biological knowledge-driven approach for drug response prediction using multi-omics data in cancer cell lines.

BMC bioinformatics·2026

This study introduces a variable string length genetic algorithm (VGA) for designing ligand molecules. VGA optimizes ligand design by allowing variable molecular structures, resulting in lower energy and docking values compared to fixed-structure methods.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Designing ligand molecules to bind target proteins is crucial in drug discovery.
  • Previous methods used fixed-structure genetic algorithms, limited by the difficulty of a priori size determination.
  • Ligand structure size varies significantly between different protein active sites.

Purpose of the Study:

  • To develop an improved evolutionary approach for designing ligand molecules with variable structures.
  • To overcome the limitations of fixed-size representations in genetic algorithms for ligand design.
  • To enhance the accuracy and efficiency of molecular docking and energy optimization.

Main Methods:

  • Implementation of a variable string length genetic algorithm (VGA).

Related Experiment Videos

  • Redesign of crossover and mutation operators to accommodate variable-length chromosomes.
  • Determination of three-dimensional molecular structures and docking energies post-evolution.
  • Testing the approach on five different target proteins.

    • Main Results:

    • Molecules designed with VGA exhibited generally lower energy values.
    • Ligand molecules evolved using VGA showed reduced docking energies compared to fixed-size methods.
    • The variable length representation successfully adapted to different target protein active sites.
    • Numerical and pictorial results demonstrated the efficacy of the VGA approach.

    Conclusions:

    • Variable string length genetic algorithms offer a more flexible and effective method for ligand design.
    • VGA overcomes the limitations of fixed-size representations in evolutionary drug design.
    • The developed method leads to improved ligand binding affinity and lower molecular energies.